1. Home
  2. Analysis
  3. Scopolamine
  4. Rezulin

Scopolamine and Rezulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Scopolamine and Rezulin together.

The phase IV clinical study analyzes what interactions people who take Scopolamine and Rezulin have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

5 people who take Scopolamine and Rezulin together, and have interactions are studied.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 3,734 Scopolamine users for its effectiveness, alternative drugs and more.

What is Rezulin?

Rezulin has active ingredients of troglitazone. eHealthMe is studying from 8,764 Rezulin users for its effectiveness, alternative drugs and more.

Number of Scopolamine and Rezulin reports submitted per year:

Scopolamine and Rezulin drug interactions.

Common Scopolamine and Rezulin drug interactions by gender *:

female:

  1. Hepatic necrosis
  2. Hepatic cirrhosis
  3. Drug eruption
  4. Dysphagia
  5. Ejection fraction
  6. Encephalopathy
  7. Fatigue
  8. Gastroenteritis viral
  9. Haematemesis
  10. Haemoptysis

male:

n/a

Common Scopolamine and Rezulin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Adrenal neoplasm
  3. Arthralgia
  4. Back pain
  5. Blood alkaline phosphatase nos increased
  6. Constipation
  7. Decreased activity
  8. Diabetes mellitus
  9. Diabetes mellitus inadequate control
  10. Diarrhoea

50-59:

n/a

60+:

  1. Hepatic cirrhosis
  2. Hepatic failure
  3. Drug eruption
  4. Dysphagia
  5. Ejection fraction
  6. Encephalopathy
  7. Gastroenteritis viral
  8. Haematemesis
  9. Haemoptysis
  10. Hoarseness

* Approximation only. Some reports may have incomplete information.

Do you take Scopolamine and Rezulin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Scopolamine and Rezulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Scopolamine side effects:

Browse all side effects of Scopolamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rezulin side effects:

Browse all side effects of Rezulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Scopolamine interactions:

Browse all interactions between Scopolamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rezulin interactions:

Browse all interactions between Rezulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine and troglitazone (the active ingredients of Scopolamine and Rezulin, respectively), and Scopolamine and Rezulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Scopolamine and Rezulin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.